and Hamed

Proud recipients of an HMR
Foundation Research Scholarship.
A significant boost for the pursuit
of their research efforts into the
treatment of septicemia and the
development of a male contraceptive.

To learn more, click here!


and Marie

In memory of Nicole Giguère,
their partner, the TOTEM’s team
decided to make a gesture
of generosity.

Read their story!


and Valentina

“When I was 21, I learned that I had
a leukemia. After two years
of treatments, they told me that
I may never be a mother.
It was a terrible shock.

Despite all of this, ten years later,
I am still here… and I am immensely
happy to introduce my little Valentina!”

Caroline Martinez-Bouchard

To learn more, click here!

Laura Groupe Banque TD 2016


“On behalf of the 26 recipients
of the 2016 Subvention TD
scholarship program, I would
like to thank the TD Bank Group
for its support. This support
enables us to pursue our studies
in the field of nursing care
at college and in university,
to develop new skills and most
of all, to make our dreams come true.”

To learn more, click here!

Every Action Counts!
Whatever the amount of your donation, you can contribute to the HMR Foundation’s cause: The welfare of our patients.




Who Are We?

As a major partner of the Hôpital Maisonneuve-Rosemont (HMR), the HMR Foundation supports the hospital, a centre affiliated with the Université de Montréal, in its strategic directions  for development in order to respond more effectively to patient needs.




Montréal Passion Vin

15th anniversary of the most prestigious wine tasting event in the country! Be among the lucky wine enthusiasts who will have the opportunity to taste several grands crus in the presence of the world’s most renowned winemakers.

What's New

Left to right : Yvan Gendron, PDG, Centre intégré universitaire de santé et de services sociaux de l’Est-de-l’Île-de-Montréal, Denis Coderre, Mayor of Montréal, Gaétan Barrette, Minister of Health and Social Services, The Honourable Kirsty Duncan, Minister of Science, Dr. Lambert Busque, Chief Medical Officer of HMR , and Christian Baron, Department of Biochemistry and Molecular Medicine of Université de Montréal
Last week, with the support of the HMR Foundation, the Hôpital Maisonneuve-Rosemont (HMR) has taken one more step forward in the battle against cancer. The Honourable Kirsty Duncan, Canada’s Minister of Science, Mr. Gaétan Barrette, Quebec Minister of Health and Social Services, Montreal Mayor Denis Coderre and numerous other partners gathered at the HMR to mark the launch of the Centre for Commercialization of Cancer Immunotherapy (C3i). Operating out of the HMR, this new centre will help refine innovative, non-toxic cancer treatments through immunotherapy. These revolutionary treatments harness the power of the immune system without using chemotherapy agents. They represent the future of medicine and they are being developed right here at the HMR! The new Centre for Commercialization of Cancer Immunotherapy (C3i) will help propel Canada to the rank of world leader in the field of cancer immunotherapy. The new centre will operate out of the HMR Centre of Excellence for Cellular Therapy (CECT) that was made possible thanks to the nearly 9 million dollars in financial support provided by the HMR Foundation and its generous donors since 2011. Today, the CECT offers the greatest expertise in cellular therapy Canada-wide and it is one of the largest stem cell transplantation centres in the country. Matthew Schreindorfer and Mai Duong, two patients who have benefited from immunotherapy treatments that are only offered at the HMR, were on site to share their gratitude and to celebrate the realization of this project that is such a beacon of hope for cancer sufferers and their loved ones.

In addition to the 15 million dollars granted by the Federal Government and the 2.5 million dollars provided by the provincial government, contributions totalling 35 million dollars from over 40 industrial partners or universities have led to the realization of this large-scale project.

CTV Click here to view the report of CTV


Support the innovation at the HMR

Cancer du sein
The Hôpital Maisonneuve-Rosemont is developing a pilot project full of hope for female cancer patients suffering from cognitive impairment associated with their treatment (chemobrain). Vital and ground-breaking in Quebec, this project has been made possible thanks to major financial support from the Quebec Breast Cancer Foundation, which is donating $350,000 as well as from the HMR Foundation and its donors, who are contributing $20,000.

The goal of this pilot project is to screen for, assess and address the cognitive issues associated with Oncology treatments that are often accompanied by related issues such as stress, loss of self-esteem, depression, anxiety, fatigue, and a perceived reduction in work ability. Of course, this constellation of cognitive, behavioural, and affective symptoms has repercussions on the lives of these women, as it affects their ability to function and their relationships, both at work and at home.

Using a multifaceted intervention, the HMR’s interdisciplinary team hopes to make the experience easier for the person affected and her loved ones when dealing with this disease and its consequences. This initiative will undoubtedly contribute to ongoing improvement in the quality of care and services provided to cancer patients, and can later be shared with other teams working with breast cancer patients throughout Quebec.

The Hospital

The Hospital

Image Hôpital Maisonneuve-Rosemont

The Hôpital Maisonneuve-Rosemont

Bâtit il y a plus de 60 ans dans l’est de Montréal, l’Hôpital Maisonneuve-Rosemont (HMR) offre des soins de qualité à ses patients intégrant le partage des connaissances, l’enseignement et la recherche. Découvrez les expertises et les spécialités qui font rayonner l’HMR bien au-delà de l’Île de Montréal.


The major campaigns and various events organized by the HMR Foundation as well as our annual campaigns have enabled the Foundation to contribute financially to the development of several large-scale HMR projects, including:
Research at the HMR: At the Heart of Your Future

The HMR Research Centre (CRHMR) is involved in fundamental, translational and clinical research activities in keeping with its clinical axes of excellence: Immunology-Oncology; Cellular Therapy; Vision Health; Nephrology. By supporting research, the HMR Foundation enables the hospital to remain a leader in many fields and supports innovation at the CRHMR.   In 2010, the Foundation contributed over 1.3 million dollars for start-up funds, clinical PhD programs and to provide income support for young researchers. Moreover, in view of the necessary upgrade of the CRHMR equipment pool, a significant portion of this amount enabled the Centre to purchase new equipment. Thanks to […]

The Centre of Excellence for Cellular Therapy

Among the most modern regenerative medicine centres in the world, the Centre of Excellence for Cellular Therapy (CECT) enables the HMR to continue its cutting edge research on stem cells, the immune system, cancer, ophthalmology and even orthopedics in order to develop treatments for a variety of illnesses as well as to play a key role in training young researchers and to bridge the gap between fundamental and clinical research. The Centre of Excellence for Cellular Therapy (CECT) opened in 2012 thanks to such clinical research visionaries as Drs Denis Claude Roy, Jean Roy, Guy Sauvageau and Claude Perreault. Its opening […]


The 2015 annual report of the HMR Foundation is now available. In 2015, we remained focused on supporting HMR’s strategic directions and better meeting patient needs. For the fifth year in a row, the HMR Foundation has ranked among the top 100 largest and best managed of Canada’s 160,000 non-profits and charitable organizations (Source: MoneySense Magazine). As honoured as we are about receiving this distinction, credit also must be given to our loyal donors, volunteers and partners who support us through their outstanding commitment.
Les soeurs D’Amours en compagnie de leur mère Claudine.
Every day, some 50 patients undergo chemotherapy treatments in the HMR Oncology Department. Those receiving these treatments sometimes have to spend as much as eight hours sitting down. The HMR Foundation appealed for donations in order to purchase new treatment chairs that can better accommodate patients’ needs. Hundreds of donors contributed to the campaign and as a result, the needs have been met... at least for now. We’d like to thank these donors from the bottom of our hearts!